Inducing effective memory T-cell responses is a major goal of vaccines against chronic infections and tumours. Here, mTOR, the mammalian target for the immunosuppressive drug rapamycin, is shown to enhance the quantity and quality of virus-specific CD8 T cells in mouse and non-human primate models.
- Koichi Araki
- Alexandra P. Turner
- Rafi Ahmed
